Sign in
RNAM Stock Price, Chart, Stats & News
Avidity Biosciences Inc
Save
Avidity Biosciences Inc (RNAM) does not currently pay a dividend.
11.26B
Market cap
–
Current P/E
–
Forward P/E
RNAM chart
Fundamentals
Gross margin | 77.87% |
Operating margin | -3977.30% |
Pretax margin | -3650.39% |
Net margin | -3650.39% |
Effective tax rate | – |
ROA | -34.96% |
ROE | -44.92% |
D/E | 0.06x |
Interest coverage ratio | – |
RNAM valuation
P/E | – |
P/S | 600.12x |
P/B | 6.44x |
P/CF | -16.72x |
P/FCF | -16.96x |
P/OCF | -16.72x |
PEG | 0.84x |
EV multiple | -15.56x |
About
Avidity Biosciences, Inc. is at the forefront of developing a novel class of oligonucleotide-based therapies, known as Antibody Oligonucleotide Conjugates (AOCs). Utilizing its proprietary AOC platform, the company engineers treatments that strategically merge the targeted delivery capabilities of monoclonal antibodies with the precise action of oligonucleotide-based therapeutics. This innovative method aims to reach cell and tissue types previously inaccessible to treatment, thereby more effectively addressing the fundamental genetic causes of various diseases.
Similar securities
Based on sector and market capitalization
Report issue